Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets
Download the PDF here.
This post appeared first on investingnews.com
Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets
Download the PDF here.
Investor Insight In the current strong market dynamic for uranium, ...
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES ...
(TheNewswire) TORONTO, ON ...